Effective Pharma Adherence Programs Start With The Patient

Patient compliance may be a core objective for pharma marketers, but an international quorum of compliance experts at the recent eyeforpharma Patient Compliance 2004 conference in London agreed that the very term 'compliance is incorrect. In 22 in-depth presentations over 2 days, 30 speakers and panelists agreed that marketers need to stop analyzing compliance, and start understanding patients.

Beyond Patient Education: Influencing Behavior Change

This article reviews how tailored behavior change programs can increase acquisition, compliance, persistency or brand loyalty. A smoking cessation program is presented as a case study.

Maximizing the DTC Message: Healthcare Businesswomen’s Association Members Evaluate DTC Marketing

How are DTC activities integrated as key components throughout the marketing mix, including advertising, advocacy and public relations? What are the risks and rewards associated with launching a DTC campaign? How have top pharmaceutical marketers managed to address sensitive health issues and drive awareness and sales through DTC? Is every drug really a viable candidate for a Direct-to-Consumer campaign? These were some of the questions discussed during an evening seminar entitled DTC Sweeps: The Impact and Evolving Role of Direct-to-Consumer Marketing.

Effective Pharma Adherence Programs Start With The Patient

Patient compliance may be a core objective for pharma marketers, but an international quorum of compliance experts at the recent eyeforpharma Patient Compliance 2004 conference in London agreed that the very term 'compliance is incorrect. In 22 in-depth presentations over 2 days, 30 speakers and panelists agreed that marketers need to stop analyzing compliance, and start understanding patients.

Accelerating Your Multicultural Communications

Multicultural communications can be a powerful addition to the armamentarium of the healthcare marketer.

Pharma Marketing News Vol. 3, #9 Preview

Vol. 3, No. 9: October 2004 - PREVIEW The following are summaries of articles planned for the upcoming October 2004 issue of Pharma Marketing News....

Drug Reimportation Issues Examined: Survey Results

This article summarizes the results of a recent Pharma Marketing News Survey on this topic.

OpEd: Spam spam spam spam. Lovely spam! Wonderful spam!

Whatever your opinion of the CAN-SPAM law and blacklists, a bright light is now focused on the spam e-mail problem. As usual, those e-mail marketers who want to obey the law have to jump through new hoops and change their business practices. Meanwhile, the real spammers will no doubt continue to outfox the regulatory agencies, attorneys general, and the ISPs and continue to spew spam at will.

OpEd: Vioxx Withdrawal and the “Me-Too Drug Domino Effect”

Vioxx Withdrawal and the "Me-Too Drug Domino Effect" OpEd by John Mack Merck's "voluntary" withdrawal of Vioxx...

Congress Fiddles While Reimportation Issue Burns

Several drug re-importation bills are currently being considered in Congress.
- Advertisement -